Cytidine deaminase single-nucleotide polymorphism is predictive of toxicity from gemcitabine in patients with pancreatic cancer: RTOG 9704

Regression Models and Life-Tables

D. R. Cox · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1972 · 39.3K citations · Full text

Public Health, Biostatistics, Hazard Identification +16

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

Medicine, Oncology, Pharmacotherapy +16

On the Interpretation of χ 2 from Contingency Tables, and the Calculation of P

R. A. Fisher · Journal Of The Royal Statistical Society · 1922 · 2.9K citations

Natural Sciences, Biostatistics, Mathematics +13

Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma

William F. Regine, Kathryn Winter, Ross A. Abrams et al. · JAMA · 2008 · 749 citations

Medicine, Oncology, Surgery +17

Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines.

John R. Mackey, Rajam S. Mani, M Selner et al. · PubMed · 1998 · 605 citations

Medicine, Oncology, Pharmacology +14